It appears the answer to your questions is a resounding "no". The US trial data is used as a support for the drug and EUA will help, but the Drug Controller General of India does not necessarily need FDA EUA. With Bucillamine having a 30 year history of being an anti inflammatory with a stellar safety rating, things could move quickly. It appears India has tried several repurposed drugs that have not worked for Covid. Maybe it is time for $RVVTF to step up to the plate with its Louisville Slugger and knock one out of the park.
News 
Market Data 
Discover 
